Literature DB >> 629283

Effect of oxytocin and oral prostaglandin E2 on uterine contractility and fetal heart rate patterns.

E A Freidman, M R Sachtleben.   

Abstract

The incidnce of uterine contractility and of abnormalities of fetal heart rate (FHR) pattern was determined in a series of 2,834 monitored gravid women with singleton pregnancies producing mature infants in vertex presentation. Those subjected to uterotonic agents for induction or augmentation of lbaor had significantly more tetanic contractions, baseline hypertonus, and coupling of contractions. Similarly, significantly more variable and late FHR decelerations occurred in stimulated labors, and these were concentrated primarily in those receiving oxytocin. The overall incidence of FHR decelerations associated with the use of prostaglandin E2 (PGE2) was comparable to that encountered in unstimulated labor. The similarity between the contractions of spontaineous labor and those labors produced by PGE2 is noted.

Entities:  

Keywords:  Abortifacient Agents; Biology; Clinical Research; Endocrine System; Fetus; Genitalia; Genitalia, Female; Hormones; Oxytocin; Physiology; Pituitary Hormones; Pregnancy; Prostaglandins; Reproduction; Research Methodology; Urogenital System; Uterine Effects; Uterus

Mesh:

Substances:

Year:  1978        PMID: 629283     DOI: 10.1016/0002-9378(78)90280-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  [Not Available].

Authors:  C Ménard
Journal:  Can Fam Physician       Date:  1979-06       Impact factor: 3.275

Review 2.  Prostaglandins in human reproduction.

Authors:  M P Embrey
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-12

3.  Enhanced Uterine Contractility and Stillbirth in Mice Lacking G Protein-Coupled Receptor Kinase 6 (GRK6): Implications for Oxytocin Receptor Desensitization.

Authors:  Chad A Grotegut; Lan Mao; Stephanie L Pierce; Geeta K Swamy; R Phillips Heine; Amy P Murtha
Journal:  Mol Endocrinol       Date:  2016-02-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.